REIT - Specialty
Compare Stocks
2 / 10Stock Comparison
AFCG vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
AFCG vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Specialty | REIT - Healthcare Facilities |
| Market Cap | $65M | $151.66B |
| Revenue (TTM) | $2M | $11.63B |
| Net Income (TTM) | $-21M | $1.43B |
| Gross Margin | 66.0% | 39.1% |
| Operating Margin | -393.9% | 4.4% |
| Forward P/E | — | 79.7x |
| Total Debt | $76M | $21.38B |
| Cash & Equiv. | $39M | $5.03B |
AFCG vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Advanced Flower Cap… (AFCG) | 100 | 19.3 | -80.7% |
| Welltower Inc. (WELL) | 100 | 302.2 | +202.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AFCG vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AFCG is the clearest fit if your priority is value and dividends.
- Better valuation composite
- 31.3% yield, vs WELL's 1.3%
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 233.9% 10Y total return vs AFCG's -44.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs AFCG's -39.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.3% margin vs AFCG's -9.8% | |
| Stability / Safety | Beta 0.13 vs AFCG's 1.86 | |
| Dividends | 31.3% yield, vs WELL's 1.3% | |
| Momentum (1Y) | +45.8% vs AFCG's -41.2% | |
| Efficiency (ROA) | 2.3% ROA vs AFCG's -7.0%, ROIC 0.5% vs -4.1% |
AFCG vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AFCG vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AFCG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 5518.0x AFCG's $2M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to AFCG's -9.8%. On growth, AFCG holds the edge at +185.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2M | $11.6B |
| EBITDAEarnings before interest/tax | -$15M | $2.8B |
| Net IncomeAfter-tax profit | -$21M | $1.4B |
| Free Cash FlowCash after capex | $11M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +66.0% | +39.1% |
| Operating MarginEBIT ÷ Revenue | -3.9% | +4.4% |
| Net MarginNet income ÷ Revenue | -9.8% | +12.3% |
| FCF MarginFCF ÷ Revenue | +5.3% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +185.4% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +174.7% | +22.5% |
Valuation Metrics
AFCG leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $65M | $151.7B |
| Enterprise ValueMkt cap + debt − cash | $103M | $168.0B |
| Trailing P/EPrice ÷ TTM EPS | -2.92x | 155.73x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 79.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 67.37x |
| Price / SalesMarket cap ÷ Revenue | 2.08x | 14.22x |
| Price / BookPrice ÷ Book value/share | 0.35x | 3.40x |
| Price / FCFMarket cap ÷ FCF | 5.80x | 53.25x |
Profitability & Efficiency
WELL leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-11 for AFCG. AFCG carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to WELL's 0.49x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs AFCG's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -11.3% | +3.5% |
| ROA (TTM)Return on assets | -7.0% | +2.3% |
| ROICReturn on invested capital | -4.1% | +0.5% |
| ROCEReturn on capital employed | -5.6% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.43x | 0.49x |
| Net DebtTotal debt minus cash | $38M | $16.3B |
| Cash & Equiv.Liquid assets | $39M | $5.0B |
| Total DebtShort + long-term debt | $76M | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | -2.02x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,193 today (with dividends reinvested), compared to $5,497 for AFCG. Over the past 12 months, WELL leads with a +45.8% total return vs AFCG's -41.2%. The 3-year compound annual growth rate (CAGR) favors WELL at 43.3% vs AFCG's -8.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -1.1% | +16.2% |
| 1-Year ReturnPast 12 months | -41.2% | +45.8% |
| 3-Year ReturnCumulative with dividends | -24.4% | +194.0% |
| 5-Year ReturnCumulative with dividends | -45.0% | +211.9% |
| 10-Year ReturnCumulative with dividends | -44.4% | +233.9% |
| CAGR (3Y)Annualised 3-year return | -8.9% | +43.3% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than AFCG's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 98.6% from its 52-week high vs AFCG's 47.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.86x | 0.13x |
| 52-Week HighHighest price in past year | $5.87 | $219.59 |
| 52-Week LowLowest price in past year | $2.06 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +47.2% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 53.1 | 57.6 |
| Avg Volume (50D)Average daily shares traded | 218K | 2.6M |
Analyst Outlook
Evenly matched — AFCG and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
For income investors, AFCG offers the higher dividend yield at 31.34% vs WELL's 1.28%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $226.50 |
| # AnalystsCovering analysts | — | 34 |
| Dividend YieldAnnual dividend ÷ price | +31.3% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.87 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
WELL leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). AFCG leads in 2 (Income & Cash Flow, Valuation Metrics). 1 tied.
AFCG vs WELL: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is AFCG or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -39. 6% for Advanced Flower Capital Inc. (AFCG). Welltower Inc. (WELL) offers the better valuation at 155. 7x trailing P/E (79. 7x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AFCG or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +211. 9%, compared to -45. 0% for Advanced Flower Capital Inc. (AFCG). Over 10 years, the gap is even starker: WELL returned +233. 9% versus AFCG's -44. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AFCG or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus Advanced Flower Capital Inc. 's 1. 86β — meaning AFCG is approximately 1297% more volatile than WELL relative to the S&P 500. On balance sheet safety, Advanced Flower Capital Inc. (AFCG) carries a lower debt/equity ratio of 43% versus 49% for Welltower Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AFCG or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -39. 6% for Advanced Flower Capital Inc. (AFCG). On earnings-per-share growth, the picture is similar: Welltower Inc. grew EPS -11. 5% year-over-year, compared to -218. 8% for Advanced Flower Capital Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AFCG or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -66. 0% for Advanced Flower Capital Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 3. 3% versus -43. 6% for AFCG. At the gross margin level — before operating expenses — AFCG leads at 90. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — AFCG or WELL?
All stocks in this comparison pay dividends.
Advanced Flower Capital Inc. (AFCG) offers the highest yield at 31. 3%, versus 1. 3% for Welltower Inc. (WELL).
07Is AFCG or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +233. 9% 10Y return). Advanced Flower Capital Inc. (AFCG) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WELL: +233. 9%, AFCG: -44. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between AFCG and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AFCG is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.